Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein

被引:28
作者
Fergusson, J
Landon, M
Lowe, J
Ward, L
van Leeuwen, FW
Mayer, RJ
机构
[1] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England
[2] Univ Nottingham, Sch Med, Clin Sci Lab, Queens Med Ctr, Nottingham NG7 2UH, England
[3] Netherlands Inst Brain Res, Grad Sch Neurosci Amsterdam, NL-1105 AZ Amsterdam, Netherlands
关键词
progressive supranuclear palsy; neurofibrillary tangle; Alzheimer's disease; ubiquitin; tau; immunohistochemistry; paired helical filaments; frameshift mutant;
D O I
10.1016/S0304-3940(99)00917-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In Alzheimer's disease (AD) neurofibrillary tangles (NFT) are strongly tau and ubiquitin immunopositive, and contain an aberrant form of ubiquitin derived from the ubiquitin-B gene denoted as UBB+1. We explored whether the tau-related NFT seen in another neurodegenerative disease, progressive supranuclear palsy (PSP), also showed an accumulation of UBB+1. Three cases of PSP were examined immunohistochemically for tau protein, ubiquitin-protein conjugates and UBB+1 using single and double labelling. We conclude that UBB+1 is associated with compact globose tangles rather than dispersed accumulations of tau in PSP, showing that its presence is not unique to AD. We propose that aggregation of ubiquitinated proteins into compact inclusions in PSP might be due to inhibition of the degradation of multiubiquitinated proteins by ubiquitin chains containing proximal UBB+1 rather than normal ubiquitin. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 12 条
[1]   Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome [J].
Fergusson, J ;
Landon, M ;
Lowe, J ;
Dawson, SP ;
Layfield, R ;
Hanger, DP ;
Mayer, RJ .
NEUROSCIENCE LETTERS, 1996, 219 (03) :167-170
[2]  
GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
[3]  
KIDD M, 1963, NATURE, V7, P279
[4]   UBIQUITIN IS A COMPONENT OF NEUROFIBRILLARY TANGLES IN A VARIETY OF NEURODEGENERATIVE DISEASES [J].
LENNOX, G ;
LOWE, J ;
MORRELL, K ;
LANDON, M ;
MAYER, RJ .
NEUROSCIENCE LETTERS, 1988, 94 (1-2) :211-217
[5]   Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders [J].
Litvan, I ;
Hauw, JJ ;
Bartko, JJ ;
Lantos, PL ;
Daniel, SE ;
Horoupian, DS ;
McKee, A ;
Dickson, D ;
Bancher, C ;
Tabaton, M ;
Jellinger, K ;
Anderson, DW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (01) :97-105
[6]  
Lowe J, 1997, GREENFIELDS NEUROPAT, P281
[7]   Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths [J].
Piotrowski, J ;
Beal, R ;
Hoffman, L ;
Wilkinson, KD ;
Cohen, RE ;
Pickart, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23712-23721
[8]  
POILACK NJ, 1986, LANCET, V2, P1211
[9]  
TAKAUCHI S, 1983, ACTA NEUROPATHOL, V59, P225, DOI 10.1007/BF00703207
[10]  
Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171